Skip to main content

Approximately 7 Percent of U.S. Population Uninsured in 2023

Medically reviewed by Carmen Pope, BPharm. Last updated on June 19, 2024.

By Elana Gotkine HealthDay Reporter

TUESDAY, June 18, 2024 -- In 2023, 7.6 percent of the U.S. civilian noninstitutionalized population was uninsured, according to early estimates from the National Health Interview Survey, 2023, released by the National Center for Health Statistics.

Robin A. Cohen, Ph.D., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues used data from the 2023 National Health Interview Survey to present health insurance coverage estimates, along with trends from 2019 through 2023.

The researchers found that 25.0 million people of all ages (7.6 percent) were uninsured at the time of the interview in 2023. This number was lower, but not significantly so, than the number seen in 2022 (27.6 million people [8.4 percent]). Among adults ages 18 to 64 years, 10.9 percent were uninsured at the time of the interview in 2023, while 23.0 and 68.1 percent had public and private health insurance coverage, respectively. Among children aged 0 to 17 years, 3.9, 44.2, and 54.0 percent were uninsured, had public coverage, and had private health insurance coverage, respectively.

In 2023, 4.8 percent of those younger than 65 years had exchange-based coverage, with higher coverage seen among males than females (5.1 versus 4.4 percent). From 2019 to 2023, there was an increase seen in the percentage of people younger than 65 years with exchange-based coverage, from 3.7 to 4.8 percent.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Glofitamab + GemOx Superior to Rituximab + GemOx for Lymphoma

WEDNESDAY, June 26, 2024 -- Glofitamab (Glofit) plus gemcitabine and oxaliplatin (GemOx) is superior to rituximab (R)-GemOx for relapsed/refractory (R/R) diffuse large B-cell...

Reported Symptoms Most Sensitive Indicator of Concussion

WEDNESDAY, June 26, 2024 -- Reported symptoms are a more accurate indicator of concussion than the 10-word component Standardized Assessment of Concussion (SAC), according to a...

USPSTF: Not Enough Evidence to Recommend Screening for Food Insecurity

WEDNESDAY, June 26, 2024 -- The U.S. Preventive Services Task Force (USPSTF) concludes that the current evidence is insufficient for recommending screening for food insecurity in...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.